Pondicherry
08048060184
+918209542042

EPLEREZONE 50

Cardiology by Eplerenone (50mg)

EPLEREZONE 50

INR 282 INR 403
Phone Number

08048060184

Please keep 0 before dialling the number.

Email Address boost@sterispharma.com

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Puducherry, India

Pondicherry, India, 0

Description

EPLEREZONE 50 Eplerenone is used alone or with other medicines to treat high blood pressure. EPLEREZONE is a selective aldosterone receptor antagonist used primarily in the management of heart failure and hypertension. By blocking the action of aldosterone, a hormone that increases sodium and water retention in the kidneys, EPLEREZONE helps to lower blood pressure and reduce the workload on the heart. Its selectivity for the aldosterone receptor allows for effective blood pressure management with a lower risk of certain side effects compared to non-selective aldosterone antagonists like spironolactone. Pharmacodynamics and Mechanism of Action: EPLEREZONE works by selectively binding to the mineralocorticoid receptors in the kidneys, heart, and blood vessels, inhibiting the action of aldosterone. This results in a decrease in sodium reabsorption and an increase in potassium retention, leading to diuresis, reduced blood volume, and, consequently, lowered blood pressure. Additionally, by reducing the fibrotic effects of aldosterone on the heart and blood vessels, EPLEREZONE can help to prevent or mitigate heart failure progression and cardiovascular mortality. Indications: EPLEREZONE is primarily indicated for: The treatment of hypertension (high blood pressure). The management of heart failure following myocardial infarction (heart attack). Contraindications and Precautions: EPLEREZONE should not be used in patients with hyperkalemia, severe renal impairment, or severe hepatic impairment. It is also contraindicated in patients taking potassium supplements, potassium-sparing diuretics, or certain medications that can increase potassium levels (e.g., NSAIDs, ACE inhibitors, ARBs) due to the increased risk of hyperkalemia. Caution is advised in patients with mild to moderate renal or hepatic impairment. For further information please contact: info@sterispharma.com / contact@sterispharma.com call/whatsapp: 8209542042, 8955945010, 6377716668 order now: https://www.sterisonline.com/product/eplerezone-50-134234

Keywords